Abstract
BackgroundGraft-vs-host-disease (GvHD) is a life-threatening complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT), limiting the use of this potentially curative treatment for hematological malignancies. To address this, we have developed...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have